Please login to the form below

Not currently logged in
Email:
Password:

dasatinib

This page shows the latest dasatinib news and features for those working in and with pharma, biotech and healthcare.

BMS’ Opdivo stalls in Q3, but overall figures still top expectations

BMS’ Opdivo stalls in Q3, but overall figures still top expectations

and leukaemia drug Sprycel (dasatinib) which brought in $558m, also up 14%.

Latest news

More from news
Approximately 3 fully matching, plus 29 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Infographics